The most appropriate treatment depends on your individual circumstances
Available toxicology data indicate a favorable safety profile in animal studies, with limited adverse effects observed across a wide range of doses
*Eligible patients lost an average of 21% of their body weight (-48 lbs) in a 72-week clinical trial evaluating 15 mg tirzepatide, when paired with diet and exercise
The NHS has used Second Nature for over 6 years, and we ensure we abide by the highest levels of data security and patient safety
CJC-1295 Ipamorelin dosage for anti-aging benefits
Why this matters: injectable GLP-1s like semaglutide and tirzepatide achieve 15 to 20% weight reductions, but injections, cost, and adherence limit real-world use (Santulli review, Journal of Diabetes & Metabolic Disorders, 2025)